News SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Real-time Estimate Cboe BZX Other stock markets 02:08:54 2024-05-09 pm EDT			5-day change	1st Jan Change
1.295 ^USD	+1.17%		-5.11%	+20.85%

May. 01	SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level	CI
Apr. 29	SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level	May. 01	AQ
SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level	May. 01	CI
SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study	Apr. 29	AQ
SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study	Apr. 29	CI
North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update	Mar. 28	AQ
SELLAS Life Sciences Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Transcript : SELLAS Life Sciences Group, Inc. - Special Call	Mar. 26
SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Steering Committee Update on Phase 3 REGAL Study	Mar. 26	AQ
SELLAS Life Sciences Group, Inc. Announces Positive Topline Data from the Phase 2a Study of Sls009 in r/r AML	Mar. 26	CI
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET	Mar. 19	AQ
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 15	MT
Top Midday Decliners	Mar. 15	MT
Sector Update: Health Care Stocks Softer Friday Afternoon	Mar. 15	MT
Sellas Life Sciences Launches $20 Million Direct Offering, Private Placement -- Shares Fall	Mar. 15	MT
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules	Mar. 15	AQ
SELLAS Life Sciences Group, Inc. announced a financing transaction	Mar. 14	CI
SELLAS Life Sciences : Material Event - Form 8-K	Mar. 11	PU
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships	Mar. 08	AQ
SELLAS Life Sciences Group, Inc. Announces Executive Changes	Mar. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Summary

Filters